CareFusion Corp. (NYSE: CFN) is buying the Vital Signs division of GE Healthcare for $500 million.
Vital Signs, headquartered in Totowa, N.J., manufactures medical products for respiratory care, anesthesiology, temperature management and pain monitoring.
CareFusion provides health care companies and hospitals with medical devices, including infusion pumps, automated dispending products and patient identification systems.
The deal expands CareFusion’s anesthesiology scale, the company says in a statement. CareFusion expects to complete the deal by the end of the year.
Paul Hastings LLP Partners Thad Malik, Deborah Sankowicz, Suzanne Horn, Eric Keller, Jim Smulkowski and Regina Engelstädter advised GE Healthcare on the deal.
Medical device deals have recently been made by HemaSource, which bought Medical Supplies of America’s blood plasma supplies division, and Forsyth Capital Investors LLC’s purchase of Vante Inc.
For more on medical devices, see “Medical Devices Drive Health Care M&A.”